289 related articles for article (PubMed ID: 33968042)
21. MAPKAP kinase 2 (MK2)-dependent and -independent models of blister formation in pemphigus vulgaris.
Mao X; Li H; Sano Y; Gaestel M; Mo Park J; Payne AS
J Invest Dermatol; 2014 Jan; 134(1):68-76. PubMed ID: 23657501
[TBL] [Abstract][Full Text] [Related]
22. Desmoglein endocytosis and desmosome disassembly are coordinated responses to pemphigus autoantibodies.
Calkins CC; Setzer SV; Jennings JM; Summers S; Tsunoda K; Amagai M; Kowalczyk AP
J Biol Chem; 2006 Mar; 281(11):7623-34. PubMed ID: 16377623
[TBL] [Abstract][Full Text] [Related]
23. [Detection of serum desmoglein antibody level using enzyme-linked immunosorbent assay (ELISA) for monitoring disease activity in patients with pemphigus vulgaris].
Zhong S; Qiu YF; Han BB; Zhao JY; Zhu XJ; Chen XX
Beijing Da Xue Xue Bao Yi Xue Ban; 2011 Jun; 43(3):414-5. PubMed ID: 21681274
[TBL] [Abstract][Full Text] [Related]
24. Clues to diagnosis for unusual mucosal pemphigus demonstrating undetectable anti-desmoglein 3 serum antibodies by routine tests.
Kamiya K; Aoyama Y; Yamaguchi M; Ukida A; Mizuno-Ikeda K; Fujii K; Hamada T; Tokura Y; Iwatsuki K
J Dermatol; 2015 Jun; 42(6):572-9. PubMed ID: 25832452
[TBL] [Abstract][Full Text] [Related]
25. Non-junctional human desmoglein 3 acts as an upstream regulator of Src in E-cadherin adhesion, a pathway possibly involved in the pathogenesis of pemphigus vulgaris.
Tsang SM; Brown L; Lin K; Liu L; Piper K; O'Toole EA; Grose R; Hart IR; Garrod DR; Fortune F; Wan H
J Pathol; 2012 May; 227(1):81-93. PubMed ID: 22294297
[TBL] [Abstract][Full Text] [Related]
26. Low pathogenicity of anti-desmoglein 3 immunoglobulin G autoantibodies contributes to the atypical clinical phenotypes in pemphigus.
Saleh MA; Hashimoto R; Kase Y; Amagai M; Yamagami J
J Dermatol; 2015 Jul; 42(7):685-9. PubMed ID: 25914046
[TBL] [Abstract][Full Text] [Related]
27. A pathogenic autoantibody, pemphigus vulgaris-IgG, induces phosphorylation of desmoglein 3, and its dissociation from plakoglobin in cultured keratinocytes.
Aoyama Y; Owada MK; Kitajima Y
Eur J Immunol; 1999 Jul; 29(7):2233-40. PubMed ID: 10427986
[TBL] [Abstract][Full Text] [Related]
28. Actin reorganization contributes to loss of cell adhesion in pemphigus vulgaris.
Gliem M; Heupel WM; Spindler V; Harms GS; Waschke J
Am J Physiol Cell Physiol; 2010 Sep; 299(3):C606-13. PubMed ID: 20554911
[TBL] [Abstract][Full Text] [Related]
29. A higher correlation of the antibody activities against the calcium-dependent epitopes of desmoglein 3 quantified by ethylenediaminetetraacetic acid-treated enzyme-linked immunosorbent assay with clinical disease activities of pemphigus vulgaris.
Kamiya K; Aoyama Y; Shirafuji Y; Hamada T; Morizane S; Fujii K; Iwatsuki K
J Dermatol Sci; 2013 Jun; 70(3):190-5. PubMed ID: 23602628
[TBL] [Abstract][Full Text] [Related]
30. Non-Desmoglein Antibodies in Patients With Pemphigus Vulgaris.
Amber KT; Valdebran M; Grando SA
Front Immunol; 2018; 9():1190. PubMed ID: 29915578
[TBL] [Abstract][Full Text] [Related]
31. Tacrolimus reverses pemphigus vulgaris serum-induced depletion of desmoglein in HaCaT cells via inhibition of heat shock protein 27 phosphorylation.
Xie Z; Dai X; Li Q; Lin S; Ye X
BMC Immunol; 2023 Nov; 24(1):43. PubMed ID: 37940861
[TBL] [Abstract][Full Text] [Related]
32. Serum and salivary IgG and IgA antibodies to desmoglein 3 in mucosal pemphigus vulgaris.
Ali S; Kelly C; Challacombe SJ; Donaldson AN; Bhogal BS; Setterfield JF
Br J Dermatol; 2016 Jul; 175(1):113-21. PubMed ID: 26799252
[TBL] [Abstract][Full Text] [Related]
33. Signaling dependent and independent mechanisms in pemphigus vulgaris blister formation.
Saito M; Stahley SN; Caughman CY; Mao X; Tucker DK; Payne AS; Amagai M; Kowalczyk AP
PLoS One; 2012; 7(12):e50696. PubMed ID: 23226536
[TBL] [Abstract][Full Text] [Related]
34. Loss of the desmosomal protein perp enhances the phenotypic effects of pemphigus vulgaris autoantibodies.
Nguyen B; Dusek RL; Beaudry VG; Marinkovich MP; Attardi LD
J Invest Dermatol; 2009 Jul; 129(7):1710-8. PubMed ID: 19158843
[TBL] [Abstract][Full Text] [Related]
35. Controversial role of antibodies against linear epitopes of desmoglein 3 in pemphigus vulgaris, as revealed by semiquantitative living cell immunofluorescence microscopy and in-cell ELISA.
Lanza A; Perillo L; Landi C; Femiano F; Gombos F; Cirillo N
Int J Immunopathol Pharmacol; 2010; 23(4):1047-55. PubMed ID: 21244754
[TBL] [Abstract][Full Text] [Related]
36. Atypical pemphigus with immunoglobulin G autoantibodies against desmoglein 3 and desmocollin 3.
Kamiya K; Aoyama Y; Wakashima C; Kudo T; Nakajima K; Sano S; Ishii N; Teye K; Hashimoto T; Iwatsuki K; Tokura Y
J Dermatol; 2016 Apr; 43(4):429-31. PubMed ID: 26331291
[TBL] [Abstract][Full Text] [Related]
37. Desmoglein 1 and 3 enzyme-linked immunosorbent assay in Iranian patients with pemphigus vulgaris: correlation with phenotype, severity, and disease activity.
Daneshpazhooh M; Chams-Davatchi C; Khamesipour A; Mansoori P; Taheri A; Firooz A; Mortazavi H; Esmaili N; Dowlati Y
J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1319-24. PubMed ID: 17958835
[TBL] [Abstract][Full Text] [Related]
38. Pathogenic IgG antibodies against desmoglein 3 in pemphigus vulgaris are regulated by HLA-DRB1*04:02-restricted T cells.
Eming R; Hennerici T; Bäcklund J; Feliciani C; Visconti KC; Willenborg S; Wohde J; Holmdahl R; Sønderstrup G; Hertl M
J Immunol; 2014 Nov; 193(9):4391-9. PubMed ID: 25252957
[TBL] [Abstract][Full Text] [Related]
39. Pemphigus vulgaris autoimmune globulin induces Src-dependent tyrosine-phosphorylation of plakophilin 3 and its detachment from desmoglein 3.
Cirillo N; AlShwaimi E; McCullough M; Prime SS
Autoimmunity; 2014 Mar; 47(2):134-40. PubMed ID: 24328683
[TBL] [Abstract][Full Text] [Related]
40. p38 MAPK activation is downstream of the loss of intercellular adhesion in pemphigus vulgaris.
Mao X; Sano Y; Park JM; Payne AS
J Biol Chem; 2011 Jan; 286(2):1283-91. PubMed ID: 21078676
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
